Conference Replays

Cardiology Update London 2021 (CULondon21)

This course contains the videos from the recorded presentations of the Cardiology Update London 2021 Conference. Since this is a replay, one can view the videos in any order they wish. No completion rule applies, regardless of the "All units must be completed" message at the bottom of the page
Happy viewing!

  • Overview and Welcome
  • Opening Lectures: Frontiers in Cardiovascular Science
  • Welcome Address | T. F. Lüscher
  • Heart age and lifetime risk – a new view on prevention | J. Deanfield
  • From herbs to pills to nucleic acid-based therapies | U. Landmesser
  • Session 1: Risk Factors and Prevention
  • The changing landscape of atherosclerosis | P. Libby
  • The new 2021 ESC Prevention Guidelines | F. Mach
  • Managing residual risk: triglycerides and Lp(a) | U. Laufs
  • How to reach new lipid targets with new drugs | F. Mach
  • Diabetes management for cardiologists – an update | N. Sattar
  • Session 2: Acute and Chronic Coronary Syndromes
  • The spectrum of ACS | T.F. Lüscher
  • My patient with acute ACS | M. Bougiakli
  • Novel approaches in the acute management of ACS | A. Banning
  • Intracoronary imaging: How does it guide management? | L.Räber
  • How to diagnose and manage MINOCA | F. Crea
  • Insights from ISCHEMIA: which treatment approach? | B. Gersh
  • Patient-tailored antithrombotic therapy after PCI | R. De Caterina
  • Session 3: Covid-19 – Impact on Heart and Lungs
  • The acute impact of Covid-19 on the cardiovascular system | S. Price
  • Covid-19 and thromboembolism | D. Gorog
  • Treatment options for Covid-19 | C. Wendtner
  • The Long Covid Syndrome | B. Raman
  • Session 4: Valve Disease
  • The 2021 ESC Guidelines on valvular heart disease | A. Vahanian
  • TAVI in aortic stenosis from inoperable to low-risk patients | B. Prendergast
  • Mitral valve disease: knife or clip? | F. Maisano
  • Tricuspid regurgitation, the new frontier | J. J. Bax
  • Session 5: Atrial Fibrillation & Arrhythmias
  • My patient with asymptomatic AF | S. Haldar
  • AF ablation: What do we achieve in patients with and without HF | G. Hindricks
  • Drug treatment of AF: current practice | A. J. Camm
  • The 2021 ESC Guidelines on Cardiac Pacing | C. Cosedis Nielsen
  • Changing indications for ICD treatment | L. Køber
  • The Paul Hamilton Wood Lecture
  • Universal definition and classification of heart failure | G. Rosano
  • Session 6: Chronic Heart Failure
  • The 2021 ESC Guidelines on Heart Failure | T. McDonagh
  • Hemodynamics of heart failure | B. A. Borlaug
  • SGLT2 inhibitors in HF and kidney disease | M. Packer
  • Pro: Towards a universal definition of HF – small or giant steps? | J. Cleland
  • Con: Towards a universal definition of HF – small or giant steps? |M. A. Pfeffer
  • Rebuttals: Towards a universal definition of HF – small or giant steps?
  • Session 7: Cardiomyopathies
  • Diagnosing hypertrophic cardiomyopathy:from genes to imaging | P. Elliott
  • Cardiac myosin inhibition in HOCM | I. Olivotto
Completion rules
  • All units must be completed